(EDEN) Edenred - Ratings and Ratios
Employee Benefits, Meal Vouchers, Mobility Cards, Fuel Cards, Corporate Payments
Dividends
| Dividend Yield | 6.43% |
| Yield on Cost 5y | 2.88% |
| Yield CAGR 5y | 12.70% |
| Payout Consistency | 93.2% |
| Payout Ratio | 58.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 35.8% |
| Value at Risk 5%th | 52.2% |
| Relative Tail Risk | -11.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.97 |
| Alpha | -42.42 |
| CAGR/Max DD | -0.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.253 |
| Beta | 0.145 |
| Beta Downside | 0.240 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.10% |
| Mean DD | 32.42% |
| Median DD | 34.47% |
Description: EDEN Edenred January 08, 2026
Edenred SE (ticker EDEN) is a French-based digital platform that delivers employee benefit, mobility and corporate payment solutions to companies, workers and merchants worldwide. Its flagship products include Ticket Restaurant for meals, Ticket Alimentación for groceries, and a suite of voucher and welfare services such as Ticket CESU, Ticket EcoCheque and Kadéos Culture, complemented by mobility offerings like Ticket Car, Ticket Fleet Pro and the EV-charging platform Spirii.
In FY 2023 the group generated roughly €6.3 billion in revenue, growing about 4 % year-on-year, with an EBITDA margin near 15 %. The business is highly sensitive to macro-drivers such as employment trends, corporate discretionary spending on employee perks, and the broader shift toward cashless, digitally managed payments-a trend that has accelerated post-COVID-19 and is reinforced by regulatory pushes for electronic transaction reporting in Europe.
Given Edenred’s exposure to both consumer-side benefit usage and B2B expense-management, analysts watch metrics like the average ticket value per user, merchant network expansion rate, and the proportion of transactions processed through its cloud-based Cintelink platform. For a deeper dive into Edenreds valuation metrics and peer comparisons, you might find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (807.0m TTM) > 0 and > 6% of Revenue (6% = 310.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 9.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -27.66% (prev -12.59%; Δ -15.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.51b > Net Income 807.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.76b) to EBITDA (2.06b) ratio: 1.82 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (247.6m) change vs 12m ago -6.36% (target <= -2.0% for YES) |
| Gross Margin 47.01% (prev 54.88%; Δ -7.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.00% (prev 20.22%; Δ 19.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.73 (EBITDA TTM 2.06b / Interest Expense TTM 282.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.45
| (A) -0.11 = (Total Current Assets 8.55b - Total Current Liabilities 9.98b) / Total Assets 13.32b |
| (B) -0.14 = Retained Earnings (Balance) -1.86b / Total Assets 13.32b |
| (C) 0.12 = EBIT TTM 1.62b / Avg Total Assets 12.95b |
| (D) -0.12 = Book Value of Equity -1.79b / Total Liabilities 14.37b |
| Total Rating: -0.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.55
| 1. Piotroski 7.0pt |
| 2. FCF Yield 16.29% |
| 3. FCF Margin 28.20% |
| 4. Debt/Equity -4.60 |
| 5. Debt/Ebitda 1.82 |
| 6. ROIC - WACC (= 25.21)% |
| 7. RoE -87.55% |
| 8. Rev. Trend 66.94% |
| 9. EPS Trend 12.77% |
What is the price of EDEN shares?
Over the past week, the price has changed by +0.24%, over one month by +5.46%, over three months by -10.38% and over the past year by -37.47%.
Is EDEN a buy, sell or hold?
What are the forecasts/targets for the EDEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31 | 64.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17.1 | -9.1% |
EDEN Fundamental Data Overview January 06, 2026
P/E Trailing = 9.0749
P/E Forward = 8.1833
P/S = 1.6596
P/EG = 0.9408
Beta = 0.391
Revenue TTM = 5.18b EUR
EBIT TTM = 1.62b EUR
EBITDA TTM = 2.06b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last quarter)
Debt = 5.35b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.76b EUR (from netDebt column, last quarter)
Enterprise Value = 8.96b EUR (4.44b + Debt 5.35b - CCE 827.0m)
Interest Coverage Ratio = 5.73 (Ebit TTM 1.62b / Interest Expense TTM 282.0m)
FCF Yield = 16.29% (FCF TTM 1.46b / Enterprise Value 8.96b)
FCF Margin = 28.20% (FCF TTM 1.46b / Revenue TTM 5.18b)
Net Margin = 15.59% (Net Income TTM 807.0m / Revenue TTM 5.18b)
Gross Margin = 47.01% ((Revenue TTM 5.18b - Cost of Revenue TTM 2.74b) / Revenue TTM)
Gross Margin QoQ = 42.87% (prev 52.17%)
Tobins Q-Ratio = 0.67 (Enterprise Value 8.96b / Total Assets 13.32b)
Interest Expense / Debt = 1.94% (Interest Expense 104.0m / Debt 5.35b)
Taxrate = 35.53% (140.0m / 394.0m)
NOPAT = 1.04b (EBIT 1.62b * (1 - 35.53%))
Current Ratio = 0.86 (Total Current Assets 8.55b / Total Current Liabilities 9.98b)
Debt / Equity = -4.60 (negative equity) (Debt 5.35b / totalStockholderEquity, last quarter -1.16b)
Debt / EBITDA = 1.82 (Net Debt 3.76b / EBITDA 2.06b)
Debt / FCF = 2.58 (Net Debt 3.76b / FCF TTM 1.46b)
Total Stockholder Equity = -921.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.23% (Net Income 807.0m / Total Assets 13.32b)
RoE = -87.55% (negative equity) (Net Income TTM 807.0m / Total Stockholder Equity -921.8m)
RoCE = 54.57% (EBIT 1.62b / Capital Employed (Equity -921.8m + L.T.Debt 3.88b))
RoIC = 28.87% (NOPAT 1.04b / Invested Capital 3.61b)
WACC = 3.66% (E(4.44b)/V(9.79b) * Re(6.55%) + D(5.35b)/V(9.79b) * Rd(1.94%) * (1-Tc(0.36)))
Discount Rate = 6.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -3.30%
[DCF Debug] Terminal Value 84.82% ; FCFF base≈949.0m ; Y1≈825.6m ; Y5≈663.0m
Fair Price DCF = 68.89 (EV 20.05b - Net Debt 3.76b = Equity 16.29b / Shares 236.5m; r=6.0% [WACC]; 5y FCF grow -15.89% → 3.0% )
EPS Correlation: 12.77 | EPS CAGR: -52.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: 66.94 | Revenue CAGR: 21.42% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=2.29 | Chg30d=-0.214 | Revisions Net=-5 | Growth EPS=-3.6% | Growth Revenue=-0.1%